Table 3.
Number of total and resistant coliform bacteria (E. coli) in hospital effluents (HEs).
| CFB (log CFU·mL−1) |
EC (log CFU·mL−1) |
|
|---|---|---|
| Total | ND-7.18 ± 0.32 | ND-4.49 ± 0.15 |
| AMP (EU) | ND-7.17 ± 0.41 | ND-4.37 ± 0.31 |
| GEN (EU) | ND-6.59 ± 0.18 | ND-3.81 ± 0.16 |
| CIP (EU) | ND-6.39 ± 0.21 | ND-3.69 ± 0.09 |
| CMP (EU) | ND-5.41 ± 0.14 | ND-2.86 ± 0.06 |
| AMP (US) | ND-7.17 ± 0.12 | ND-4.35 ± 0.11 |
| GEN (US) | ND-6.45 ± 0.22 | ND-3.63 ± 0.08 |
| CIP (US) | ND-5.79 ± 0.17 | ND-3.59 ± 0.14 |
| CMP (US) | ND-5.00 ± 0.25 | ND-2.62 ± 0.19 |
| TET (US) | ND-5.86 ± 0.09 | ND-3.73 ± 0.07 |
CFB—coliform bacteria, EC—E. coli, AMP—ampicillin, GEN—gentamicin, CIP—ciprofloxacin, CMP—chloramphenicol, TET—tetracycline, ND—not detected, EU—resistance breakpoints according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST), US—resistance breakpoints according to the Clinical Laboratory Standards Institute (CLSI).